Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018

SELL
$23.62 - $42.29 $30,611 - $54,807
-1,296 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$22.49 - $34.56 $4,835 - $7,430
215 Added 19.89%
1,296 $33,000
Q4 2017

Jan 25, 2018

BUY
$20.44 - $35.56 $6,499 - $11,308
318 Added 41.68%
1,081 $29,000
Q3 2017

Nov 01, 2017

BUY
$23.54 - $38.21 $17,961 - $29,154
763
763 $29,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.58B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.